1.0% C31G SAVVY vaginal gel
9784
Phase 3 small_molecule active
Quick answer
1.0% C31G SAVVY vaginal gel for HIV Infections is a Phase 3 program (small_molecule) at United Therapeutics Europe Ltd with 2 ClinicalTrials.gov record(s).
Program details
- Company
- United Therapeutics Europe Ltd
- Indication
- HIV Infections
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active